FRIDAY, March 7, 2025 (HealthDay News) — The number of people with Parkinson’s disease will more than double by 2050, driven by the aging of the global population, a new study suggests. In all, 25.2 million people will be living with Parkinson’s by 2050, researchers project in The BMJ. “AnContinue Reading
MONDAY, March 3, 2025 — A patient with multiple autoimmune diseases can remember the exact moment a doctor tore their heart out. “One doctor told me I was making myself feel pain, and I still can’t forget those words,” the patient remembered. “Telling me I’m doing it to myself hasContinue Reading
WEDNESDAY, Feb. 19, 2025 (HealthDay News) — Lupus can do irreversible harm to a person’s organs, damaging the lungs, kidneys, heart, liver and other vital organs through inflammation. But a newer lupus drug appears to protect patients from much of this organ damage, a new study suggests. Anifrolumab (brand nameContinue Reading
Onapgo is a subcutaneous apomorphine infusion device for the treatment of motor fluctuations in patients with advanced diseaseContinue Reading
WEDNESDAY, Feb. 5, 2025 (HealthDay News) — Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson’s disease have taken an hit. A new study found that a drug in the same class called exenatide, marketed as Byetta, had no effect on slowing the disease or easingContinue Reading
WEDNESDAY, Jan. 15, 2024 (HealthDay News) — People with lupus-related skin problems are more likely to develop heart disease associated with hardening of the arteries. Lupus patients with skin symptoms are 72% more likely to develop atherosclerotic heart disease, in which arteries become clogged and less flexible, researchers reported inContinue Reading
THURSDAY, Jan. 9, 2025 (HealthDay News) — A pain-relieving medication might be safer for seniors than first thought. A new study published Jan. 7 in the Annals of Internal Medicine says Gabapentin is widely used to help treat chronic pain and nerve pain, particularly as an alternative to opioid painkillers.Continue Reading
THURSDAY, Dec. 19, 2024 (HealthDay News) — Parkinson’s is a relentless disease for which few treatments, and no real cure, exists. Now, researchers say they are on the trail of a potential new therapy for the disabling neurological illness. It’s early research, still in the animal-testing stage, as explained byContinue Reading
WEDNESDAY, Nov. 27, 2024 (HealthDay News) — The blood-brain barrier is a natural membrane that protects your brain from toxins and germs. Unfortunately, this barrier also hampers the delivery of important medicines and therapies into the brain. But researchers now think they’ve figured out a way to get drugs pastContinue Reading
FRIDAY, Nov. 15, 2024 (HealthDay News) — Cases of the autoimmune skin condition eczema appear to rise in areas most plagued by air pollution, new research shows. Since data has long shown that rates of eczema — clinically known as atopic dermatitis — increase along with industrialization, dirty air mightContinue Reading